We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Two-year data from an early feasibility ...
Photo Credit: Adapted from von Bardeleben RS. Tricuspid TEER is the first choice to treat TR – updates from bRIGHT and TRILUMINATE Pivotal. Presented at: TCT 2022. Boston, MA. A higher tricuspid valve ...
TCT 79: Impact of sex on clinical outcomes in patients undergoing complex percutaneous coronary angioplasty ((from the e-ULTIMASTER Study). Receive the the latest news, research, and presentations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback